A founder mutation in the TCIRG1 gene causes osteopetrosis in the Ashkenazi Jewish population

Clin Genet. 2015 Jul;88(1):74-9. doi: 10.1111/cge.12448. Epub 2014 Jul 31.

Abstract

Osteopetrosis is a rare and heterogeneous genetic disorder characterized by dense bone mass that is a consequence of defective osteoclast function and/or development. Autosomal recessive osteopetrosis (ARO) is the most severe form and is often fatal within the first years of life; early hematopoietic stem cell transplant (HSCT) remains the only curative treatment for ARO. The majority of the ARO-causing mutations are located in the TCIRG1 gene. We report here the identification and characterization of an A to T transversion in the fourth base of the intron 2 donor splice site (c.117+4A→T) in TCIRG1, a mutation not previously seen in the Ashkenazi Jewish (AJ) population. Analysis of a random sample of individuals of AJ descent revealed a carrier frequency of approximately 1 in 350. Genotyping of five loci adjacent to the c.117+4A→T-containing TCIRG1 allele revealed that the presence of this mutation in the AJ population is due to a single founder. The identification of this mutation will enable population carrier testing and will facilitate the identification and treatment of individuals homozygous for this mutation.

Keywords: Ashkenazi Jewish; TCIRG1; founder mutation; osteopetrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Mutational Analysis
  • Founder Effect*
  • Gene Frequency
  • Humans
  • Infant
  • Introns
  • Jews / genetics
  • Osteopetrosis / genetics*
  • Point Mutation*
  • RNA Splice Sites / genetics*
  • Vacuolar Proton-Translocating ATPases / genetics*

Substances

  • RNA Splice Sites
  • TCIRG1 protein, human
  • Vacuolar Proton-Translocating ATPases